Psychosis has largely been associated with dopaminergic dysregulation mediated by D2 dopamine receptors in the striatum, and dopaminergic agents which are either antipsychotic or raise the risk of psychosis (e.g. amphetamine) primarily work by acting as antagonists or agonists on these receptors, respectively. This evidence concerns the gene DRD2 and psychotic disorder.